These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 28872078)
1. [Correlations between the p-Akt-mTOR-p70S6K pathway and clinicopathological features or chemoresistance of ovarian cancer]. Liu W; Wang Q; Li F; Zhang S; Cao L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 42(8):882-888. PubMed ID: 28872078 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [TBL] [Abstract][Full Text] [Related]
3. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides. Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026 [TBL] [Abstract][Full Text] [Related]
4. Activation of Akt/mTOR pathway is associated with poor prognosis of nasopharyngeal carcinoma. Wang W; Wen Q; Xu L; Xie G; Li J; Luo J; Chu S; Shi L; Huang D; Li J; Fan S PLoS One; 2014; 9(8):e106098. PubMed ID: 25165983 [TBL] [Abstract][Full Text] [Related]
5. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer. Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414 [TBL] [Abstract][Full Text] [Related]
6. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma. Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319 [TBL] [Abstract][Full Text] [Related]
7. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma. Tasioudi KE; Sakellariou S; Levidou G; Theodorou D; Michalopoulos NV; Patsouris E; Korkolopoulou P; Saetta AA APMIS; 2015 Aug; 123(8):639-47. PubMed ID: 25912437 [TBL] [Abstract][Full Text] [Related]
10. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. No JH; Jeon YT; Park IA; Kim YB; Kim JW; Park NH; Kang SB; Han JY; Lim JM; Song YS Gynecol Oncol; 2011 Apr; 121(1):8-12. PubMed ID: 21276607 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Castellvi J; Garcia A; Rojo F; Ruiz-Marcellan C; Gil A; Baselga J; Ramon y Cajal S Cancer; 2006 Oct; 107(8):1801-11. PubMed ID: 16983702 [TBL] [Abstract][Full Text] [Related]
12. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. Xiao L; Wang YC; Li WS; Du Y J Exp Clin Cancer Res; 2009 Dec; 28(1):152. PubMed ID: 20003385 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma. Wang Y; Sun J; Yao N Eur J Histochem; 2021 Nov; 65(4):. PubMed ID: 34783234 [TBL] [Abstract][Full Text] [Related]
14. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma]. Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer. Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970 [TBL] [Abstract][Full Text] [Related]
16. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995 [TBL] [Abstract][Full Text] [Related]
17. Activation of Akt-mTOR-p70S6K pathway in angiogenesis in hepatocellular carcinoma. Li W; Tan D; Zhang Z; Liang JJ; Brown RE Oncol Rep; 2008 Oct; 20(4):713-9. PubMed ID: 18813808 [TBL] [Abstract][Full Text] [Related]
18. The Mammalian Target of Rapamycin-70-kDa Ribosomal Protein S6 Kinase Axis Inhibits the Biological Function of Tongue Squamous Cell Carcinoma. Yi C; Huang Z; Huang Z; Zhao X; Li H; Wang J J Oral Maxillofac Surg; 2019 Sep; 77(9):1928-1940. PubMed ID: 30339792 [TBL] [Abstract][Full Text] [Related]
19. Effects of MFG-E8 expression on the biological characteristics of ovarian cancer cells via the AKT/mTOR/S6K signalling pathway. Li N; Wang Y; Liu L; Wang P; Wu X J Obstet Gynaecol; 2023 Dec; 43(1):2151354. PubMed ID: 36484512 [TBL] [Abstract][Full Text] [Related]
20. Delicaflavone induces autophagic cell death in lung cancer via Akt/mTOR/p70S6K signaling pathway. Sui Y; Yao H; Li S; Jin L; Shi P; Li Z; Wang G; Lin S; Wu Y; Li Y; Huang L; Liu Q; Lin X J Mol Med (Berl); 2017 Mar; 95(3):311-322. PubMed ID: 27838742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]